Rybelsus vs. Ozempic: daily semaglutide pill or weekly shot?

Semaglutide is a peptide, and stomach acid normally breaks peptides down. The tablets add an absorption enhancer called SNAC, which lets a small share of each dose cross the stomach wall. That chemistry is the reason for the tablet's routine: take it on waking, on an empty stomach, with up to 4 ounces of plain water, swallowed whole. Then wait at least 30 minutes before food, other drinks or other pills.

Rybelsus steps from 3 mg for 30 days to 7 mg, then 14 mg if more control is needed. The Ozempic pill is a newer, more absorbable formulation that steps from 1.5 mg to 4 mg, then 9 mg. The shared tablet label says the two lines are not interchangeable milligram for milligram: 7 mg Rybelsus corresponds to 4 mg Ozempic pill, and 14 mg to 9 mg.

Ozempic injection runs 0.25 mg, 0.5 mg, 1 mg and 2 mg once weekly, on any day and at any time, with or without food. It goes into the belly, thigh or upper arm.

No trial has tested Rybelsus directly against Ozempic. Each route was studied against other treatments, so the comparison is indirect.

The tablet. PIONEER 4 (Lancet, 2019) randomized 711 adults to oral semaglutide 14 mg, liraglutide injection or placebo. At 26 weeks, HbA1c fell 1.2 percentage points on the tablet, 1.1 on liraglutide and 0.2 on placebo, and the tablet produced more weight loss than either. SOUL (NEJM, 2025) followed 9,650 high-risk adults for a median of about four years. Oral semaglutide lowered major cardiovascular events by 14% versus placebo (hazard ratio 0.86). The FDA added a heart-risk indication for the 7 mg and 14 mg tablets in October 2025.

The injection. In SUSTAIN FORTE (Lancet Diabetes & Endocrinology, 2021), Ozempic 2 mg lowered HbA1c by 2.2 points over 40 weeks, against 1.9 points on 1 mg. Ozempic also carries heart-risk and kidney indications, the latter from the FLOW trial.

Reading them together. The trials used different people and comparators, so any gap between them is an estimate. A Cleveland Clinic endocrinologist notes that oral absorption is lower than injection. Following the fasting rules exactly is what lets the tablet dose work as labeled.

Expect the same kinds of effects from either route, led by the gut. The numbers below come from separate trials, so compare them loosely.

The tablet prescribing information reports, at 14 mg: nausea 20%, abdominal pain 11%, diarrhea 10%, decreased appetite 9%, vomiting 8% and constipation 5%. The Ozempic injection label reports nausea in 15.8% on 0.5 mg and 20.3% on 1 mg, vomiting in 5% and 9.2%, and diarrhea in 8.5% and 8.8%.

The tablet has one interaction the shot does not stress: in a label study, taking it with levothyroxine raised thyroid hormone exposure by 33%, so thyroid levels may need checking. Both slow stomach emptying, which can change how other oral drugs absorb.

Rarer risks are shared. They include pancreatitis, gallbladder disease, kidney injury from dehydration and worsening diabetic retinopathy. Low blood sugar mostly happens with insulin or a sulfonylurea. The rodent thyroid C-cell tumor boxed warning applies to both, and both are contraindicated with medullary thyroid carcinoma or MEN 2 in you or your family.

The tablet suits people who would rather not inject and can protect a 30-minute window every morning. It works best when mornings already follow a fixed pattern.

The injection suits people with irregular mornings or shift work. It also suits people who take several morning pills with their own timing rules. And it suits anyone whose HbA1c needs the extra room a 2 mg weekly dose gives.

Current Rybelsus users need a new prescription to move to the Ozempic pill, according to Novo Nordisk. Novo also advises against switching between the two tablet lines during the start-up steps. Ask your prescriber which strength matches your current dose.

Neither suits weight management without diabetes. No Ozempic or Rybelsus product is approved for that; the Wegovy pill and Wegovy injection are. Neither is recommended with severe gastroparesis.

Cost often settles it. Coverage for both tends to follow a type 2 diabetes diagnosis. Check what your plan covers before choosing a route.